GSK is paying $66 million upfront to license rights to Spero Therapeutics novel antibiotic tebipenem Hbr, unswayed by the FDA's decision earlier this year not to approve the drug for adults with ...
The FDA's decision not to approve Spero Therapeutics' oral antibiotic tebipenem Hbr for adults with complicated urinary tract infections (cUTI) further increases the threat of antibiotic ...
A Maryland native, Chef Johnny Spero staged around the world at restaurants such as Mugaritz and Noma prior to returning to the Washington, D.C. area and working for José Andrés’ Minibar.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback